1. LSD1 downregulates p21 expression in vascular smooth muscle cells and promotes neointima formation.
- Author
-
Yuan B, Liu H, Pan X, Dong X, Qu LF, Sun J, and Pan LL
- Subjects
- Animals, Becaplermin metabolism, Becaplermin pharmacology, Cell Movement, Cell Proliferation, Cells, Cultured, Humans, Lysine metabolism, Mice, Muscle, Smooth, Vascular cytology, Carotid Artery Injuries genetics, Carotid Artery Injuries metabolism, Histone Demethylases genetics, Histone Demethylases metabolism, Myocytes, Smooth Muscle metabolism, Neointima metabolism
- Abstract
Neointima formation is characterized by the proliferation of vascular smooth muscle cells (VSMC). Although lysine-specific demethylase 1 (LSD1) has critical functions in several diseases, its role in neointima formation remains to be clarified. In this study, we aimed to explore the crucial role of LSD1 on neointima formation using a carotid artery injury model in mice. We observed that aberrant LSD1 expression was increased in human and mouse stenotic arteries and platelet-derived growth factor-BB (PDGF-BB)-treated VSMC. Furthermore, LSD1 knockdown significantly mitigated neointima formation in vivo and inhibited PDGF-BB-induced VSMC proliferation in vitro. We further uncovered that LSD1 overexpression exhibited opposite phenotypes in vivo and in vitro. Finally, LSD1 knockdown inhibited VSMC proliferation by increasing p21 expression, which is associated with LSD1 mediated di-methylated histone H3 on lysine 4 (H3K4me2) modification. Taken together, our data suggest that LSD1 may be a potential therapeutic target for the treatment of neointima formation., (Copyright © 2022. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF